Literature DB >> 15028284

Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein.

Rajesh Ambasudhan1, XiaoFei Wang, Monica M Jablonski, Debra A Thompson, Pamela S Lagali, Paul W Wong, Paul A Sieving, Radha Ayyagari.   

Abstract

Elongation of very long chain fatty acids 4 (ELOVL4) is a novel member of the ELO family of genes that are involved in fatty acid metabolism. ELOVL4 encodes a putative transmembrane protein of 314 amino acids that carries a possible endoplasmic reticulum (ER) retention/retrieval signal (KXKXX) at the C-terminus. Two distinct mutations, a 5-bp deletion and a complex mutation from the same region in exon 6 of this gene, have been reported so far and are associated with autosomal dominant atrophic macular degeneration (adMD/STGD3). Both of these deletions could result in C-terminal truncation and loss of the ER retention signal in the mutant protein. We expressed the wild-type and mutant proteins in COS-7 and CHO cells to study the intracellular distribution of ELOVL4 and to identify possible implications of the above mutations in its localization. Immunofluorescence analysis of these proteins along with organelle marker antibodies revealed predominant ER localization for wild-type ELOVL4. Targeted deletion of the dilysine motif at the C-terminus of the protein resulted in the loss of ER localization. Immunoelectron microscopy and immunofluorescence analysis revealed a similar ER localization pattern for the protein in human photoreceptors. These data indicate that ELOVL4 is an ER-resident protein, which supports its suggested function in fatty acid elongation. We also demonstrate that the localization of both mutant proteins was dramatically changed from an ER to a Golgi distribution. Our observations suggest that the consequences of defective protein trafficking could underlie the molecular mechanism associated with degeneration of the macula in the patients with adMD/STGD3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028284     DOI: 10.1016/j.ygeno.2003.10.004

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  30 in total

1.  Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death.

Authors:  Vidyullatha Vasireddy; Yoshikazu Uchida; Norman Salem; Soo Yeon Kim; Md Nawajesh Ali Mandal; Geereddy Bhanuprakash Reddy; Ravi Bodepudi; Nathan L Alderson; Johnie C Brown; Hiroko Hama; Andrzej Dlugosz; Peter M Elias; Walter M Holleran; Radha Ayyagari
Journal:  Hum Mol Genet       Date:  2007-01-05       Impact factor: 6.150

Review 2.  Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein.

Authors:  Martin-Paul Agbaga; Md Nawajes A Mandal; Robert E Anderson
Journal:  J Lipid Res       Date:  2010-03-18       Impact factor: 5.922

3.  Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.

Authors:  Dorit Raz-Prag; Radha Ayyagari; Robert N Fariss; Md Nawajes A Mandal; Vidyullatha Vasireddy; Sharon Majchrzak; Andrea L Webber; Ronald A Bush; Norman Salem; Konstantin Petrukhin; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

4.  Mouse Models of Stargardt 3 Dominant Macular Degeneration.

Authors:  Peter Barabas; Aruna Gorusupudi; Paul S Bernstein; David Krizaj
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

5.  Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration.

Authors:  G Karan; C Lillo; Z Yang; D J Cameron; K G Locke; Y Zhao; S Thirumalaichary; C Li; D G Birch; H R Vollmer-Snarr; D S Williams; K Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-04       Impact factor: 11.205

6.  A Stargardt disease-3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32-C36 acyl phosphatidylcholines.

Authors:  Anne McMahon; Shelley N Jackson; Amina S Woods; Wojciech Kedzierski
Journal:  FEBS Lett       Date:  2007-11-05       Impact factor: 4.124

7.  Hetero-oligomeric interactions of an ELOVL4 mutant protein: implications in the molecular mechanism of Stargardt-3 macular dystrophy.

Authors:  Ayaka Okuda; Tatsuro Naganuma; Yusuke Ohno; Kensuke Abe; Maki Yamagata; Yasuyuki Igarashi; Akio Kihara
Journal:  Mol Vis       Date:  2010-11-18       Impact factor: 2.367

8.  Inner retina remodeling in a mouse model of stargardt-like macular dystrophy (STGD3).

Authors:  Sharee Kuny; Frédéric Gaillard; Silvina C Mema; Paul R Freund; Kang Zhang; Ian M Macdonald; Janet R Sparrow; Yves Sauvé
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

9.  Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.

Authors:  Peter Barabas; Aihua Liu; Wei Xing; Ching-Kang Chen; Zongzhong Tong; Carl B Watt; Bryan W Jones; Paul S Bernstein; David Križaj
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

Review 10.  Genetics and molecular pathology of Stargardt-like macular degeneration.

Authors:  Vidyullatha Vasireddy; Paul Wong; Radha Ayyagari
Journal:  Prog Retin Eye Res       Date:  2010-01-21       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.